Αρχειοθήκη ιστολογίου

Παρασκευή 21 Ιουλίου 2017

Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

Condition:   Lung Cancer Interventions:   Drug: Pembrolizumab;   Drug: Guadecitabine;   Drug: Mocetinostat Sponsors:   Memorial Sloan Kettering Cancer Center;   Merck Sharp & Dohme Corp.;   Astex Pharmaceuticals;   Mirati Therapeutics Inc. Not yet recruiting - verified July 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uJLPpW
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,

Αναζήτηση αυτού του ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader